Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study in Smokers Using THS 2.2 With 5 Days in a Confinement Setting.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting: primary endpoint results, effect estimate with confidence…
- Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting Followed by 86 Days in an Ambulatory Setting: primary endpoint results, effect estimate with…
- Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: Complete Statistical AnalysisIndependent statistical analysis of Reduced Exposure to HPHC in Smokers Switching From Cigarettes to Different Versions of THS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission: primary endpoint results, effect estimate with confidence…
- Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc): Complete Statistical AnalysisIndependent statistical analysis of Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease: primary endpoint results, effect…
- Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: Complete Statistical AnalysisIndependent statistical analysis of Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: Complete Statistical AnalysisIndependent statistical analysis of Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REDUCEhfIndependent statistical analysis of Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ReducerIndependent statistical analysis of Feasibility and Efficacy of Coronary Sinus Narrowing in Patients With Coronary Microvascular Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reducing Adolescent Pregnancy in the Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Reducing Adolescent Pregnancy in the Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04744155).
- Reducing Adolescent Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Reducing Adolescent Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04120376).
- Reducing Aerosol and Bioaerosol Using Different Oral Suctions: Complete Statistical AnalysisIndependent statistical analysis of Reducing Aerosol and Bioaerosol Using Different Oral Suctions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05848245).
- Reducing Assessment Barriers for Patients With Low Literacy: Complete Statistical AnalysisIndependent statistical analysis of Reducing Assessment Barriers for Patients With Low Literacy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03584490).
- Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Reducing Asymmetry During Gait Using the TPAD (Tethered Pelvic Assist Device) for Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Reducing Bacteria That Cause Tooth Decay: Complete Statistical AnalysisIndependent statistical analysis of Reducing Bacteria That Cause Tooth Decay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03062605).
- Reducing Children’s Anxiety Using Homeopathic Remedy Before Dental Treatment: Complete Statistical AnalysisIndependent statistical analysis of Reducing Children's Anxiety Using Homeopathic Remedy Before Dental Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01658059).
- Reducing Falls With RENEW in Older Adults Who Have Fallen: Complete Statistical AnalysisIndependent statistical analysis of Reducing Falls With RENEW in Older Adults Who Have Fallen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01080196).
- Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid: Complete Statistical AnalysisIndependent statistical analysis of Reducing Hemarthrosis in Tibial Tubercle Osteotomy by the Administration of Intravenous Tranexamic Acid: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reducing HIV Risk Among Adolescents: Evaluating Project HEART: Complete Statistical AnalysisIndependent statistical analysis of Reducing HIV Risk Among Adolescents: Evaluating Project HEART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02579135).
- Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Reducing Hypotensive Anesthesia Use With TXA During Orthognathic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05474027).
- Reducing Metabolic Syndrome Among Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Reducing Metabolic Syndrome Among Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03719677).
- Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: Complete Statistical AnalysisIndependent statistical analysis of Reducing Operative and Post-operative Morbidity in Living Kidney Donors With the Airseal System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reducing Pain of Lidocaine Injection: Complete Statistical AnalysisIndependent statistical analysis of Reducing Pain of Lidocaine Injection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02288364).
- Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania: Complete Statistical AnalysisIndependent statistical analysis of Reducing Post-Hospital Mortality in HIV-infected Adults in Tanzania: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03858998).
- Reducing Preterm Births in Underserved Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Reducing Preterm Births in Underserved Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01344616).
- Reducing Traffic Pollution Exposure Improves Blood Pressure: Complete Statistical AnalysisIndependent statistical analysis of Reducing Traffic Pollution Exposure Improves Blood Pressure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04029129).
- Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion: Complete Statistical AnalysisIndependent statistical analysis of Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Reduction in the Occurrence of Center-Involved Diabetic Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of Reduction in the Occurrence of Center-Involved Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00090519).
- Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking: Complete Statistical AnalysisIndependent statistical analysis of Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to THS Use Compared to Cigarette Smoking: primary endpoint results, effect estimate with confidence…
- Reduction of Risk for Low Back Injury in Theater of Operations: Complete Statistical AnalysisIndependent statistical analysis of Reduction of Risk for Low Back Injury in Theater of Operations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REDWOOD-HCMIndependent statistical analysis of Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- REFALSIndependent statistical analysis of Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Refametinib (BAY86-9766) in Combination With Regorafenib (Stivarga, BAY73-4506) in Patients With Advanced or Metastatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Refining the Shared Decision Making Process Survey in ADHD Medication Decisions: Complete Statistical AnalysisIndependent statistical analysis of Refining the Shared Decision Making Process Survey in ADHD Medication Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Refitting Frequent Replacement Lens Wearers Into Clariti 1 Day And 1-Day Acuvue Moist Daily Disposable Spherical Lenses: Complete Statistical AnalysisIndependent statistical analysis of Refitting Frequent Replacement Lens Wearers Into Clariti 1 Day And 1-Day Acuvue Moist Daily Disposable Spherical Lenses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: Complete Statistical AnalysisIndependent statistical analysis of Refitting Somofilcon A Sphere Contact Lens Wearers Into Fanfilcon A Sphere Lenses for 4-Weeks of Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- REFLECTIndependent statistical analysis of REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REFLECT-2Independent statistical analysis of Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- REFLEXIONIndependent statistical analysis of Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00813709).
- ReFOCUS1Independent statistical analysis of Reducing Frailty for Older Cancer Survivors Using Supplements: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04553666).
- REFORMSIndependent statistical analysis of RNF and Betaseron® Tolerability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00428584).
- REFRESHIndependent statistical analysis of RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01490086).
- REFRESHIndependent statistical analysis of CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02566525).
- Regadenoson Real Time Perfusion Imaging Trial-Optison: Complete Statistical AnalysisIndependent statistical analysis of Regadenoson Real Time Perfusion Imaging Trial-Optison: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01489176).
- REGAINIndependent statistical analysis of Regional Versus General Anesthesia for Promoting Independence After Hip Fracture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02507505).
- ReGaiNIndependent statistical analysis of Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00824746).
- REGAiN-1AIndependent statistical analysis of Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…